Dorairaj Syril K

Vasu Pranav, Dorairaj Emily A, Weinreb Robert N, Huang Alex S, Dorairaj Syril K

In non-diabetic obese patients, GLP-1RAs significantly reduced the risk of primary open-angle glaucoma and ocular hypertension compared to other weight loss medications, suggesting a potential protective effect for eye health.

Bravetti Giorgio Enrico, Gillmann Kevin, Salinas Lauriane, Berdahl John P, Lazcano-Gomez Gabriel S, Williamson Blake K et al.

KDB goniotomy for severe glaucoma significantly lowered IOP and medication use over 12 months, showing good safety. This offers a useful treatment option for high-risk eyes.

Shah Parth, Varikuti Venkata N V, Rai Oshin, Chaves Ariel, Miranda Alex, Lim Boon-Ang et al.

Sieminski Sandra F, Varikuti Venkata N V, Shah Parth, Rai Oshin, Chaves Ariel, Miranda Alex et al.

Varikuti Venkata N V, Shah Parth, Rai Oshin, Chaves Ariel C, Miranda Alex, Lim Boon-Ang et al.

MP-TSCPC effectively lowered IOP and medication use in glaucoma patients with good vision, without significantly reducing visual acuity, suggesting it's a viable early treatment alternative to incisional surgery.

Salinas Lauriane, Chaudhary Ankita, Berdahl John P, Lazcano-Gomez Gabriel S, Williamson Blake K, Dorairaj Syril K et al.

Salinas Lauriane, Chaudhary Ankita, Berdahl John P, Lazcano-Gomez Gabriel S, Williamson Blake K, Dorairaj Syril K et al.

Goniotomy with Kahook Dual Blade in severe glaucoma significantly lowered eye pressure and medication use at 6 months, offering a safe surgical alternative.

Pant Anup Dev, Gogte Priyanka, Pathak-Ray Vanita, Dorairaj Syril K, Amini Rouzbeh

This study found irises in angle-closure glaucoma patients are significantly stiffer than healthy controls. This suggests iris stiffness is a PACG risk factor, potentially leading to new stiffness-lowering treatments.

Greenwood Michael D, Seibold Leonard K, Radcliffe Nathan M, Dorairaj Syril K, Aref Ahmad A, Román Jesús Jimenez et al.

Single-use dual blade goniotomy with cataract surgery significantly lowered IOP and medication use in glaucoma patients for 6 months, offering an effective treatment option.

Parekh Anjali S, Weinreb Robert N, Dorairaj Syril K